OrthoVet ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 0.0% 4.3% 1.7%  
Credit score (0-100)  0 0 0 47 71  
Credit rating  N/A N/A N/A BBB A  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 10.4  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 0.0 401 10,796  
EBITDA  0.0 0.0 0.0 -40.7 6,830  
EBIT  0.0 0.0 0.0 -138 6,248  
Pre-tax profit (PTP)  0.0 0.0 0.0 -182.9 6,169.9  
Net earnings  0.0 0.0 0.0 -122.7 4,830.0  
Pre-tax profit without non-rec. items  0.0 0.0 0.0 -183 6,170  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 3,076 2,868  
Shareholders equity total  0.0 0.0 0.0 677 6,707  
Interest-bearing liabilities  0.0 0.0 0.0 3,104 0.0  
Balance sheet total (assets)  0.0 0.0 0.0 4,553 8,155  

Net Debt  0.0 0.0 0.0 2,348 -3,654  
 
See the entire balance sheet

Volume 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 0.0 401 10,796  
Gross profit growth  0.0% 0.0% 0.0% 0.0% 2,591.2%  
Employees  0 0 0 1 6  
Employee growth %  0.0% 0.0% 0.0% 0.0% 500.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 0 4,553 8,155  
Balance sheet change%  0.0% 0.0% 0.0% 0.0% 79.1%  
Added value  0.0 0.0 0.0 -137.8 6,830.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 2,979 -790  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 0.0 -1.0 1.0  

Profitability 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 0.0% -34.3% 57.9%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 0.0% -3.0% 98.6%  
ROI %  0.0% 0.0% 0.0% -3.6% 116.9%  
ROE %  0.0% 0.0% 0.0% -18.1% 130.8%  

Solidity 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Equity ratio %  0.0% 0.0% 0.0% 14.9% 82.3%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 0.0% -5,772.3% -53.5%  
Gearing %  0.0% 0.0% 0.0% 458.3% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 2.9% 6.0%  

Liquidity 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Quick Ratio  0.0 0.0 0.0 0.4 4.1  
Current Ratio  0.0 0.0 0.0 0.4 4.3  
Cash and cash equivalent  0.0 0.0 0.0 756.1 3,653.9  

Capital use efficiency 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 0.0 -2,398.7 4,060.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
N/A
2021
N/A
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 -138 1,138  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 -41 1,138  
EBIT / employee  0 0 0 -138 1,041  
Net earnings / employee  0 0 0 -123 805